Search research articles
Contact Us
Filters
Showing results (431-440 of 531) with videos related to
Page
of 54
Sort By:
Microbiology Spectrum
|
March 29, 2022
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections <i>In Vitro</i>: Bacteriophage-Antibiotic Combination
Razieh Kebriaei, Katherine L Lev, Rahi M Shah, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an <i>In Vitro</i> Biofilm Model
Seyedehameneh Jahanbakhsh, Nivedita B Singh, Juwon Yim, et al.
Antimicrobial Agents and Chemotherapy
|
November 30, 2016
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Evan J Zasowski, Trang D Trinh, Kimberly C Claeys, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2015
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure
Justin R Lenhard, Tanya Brown, Michael J Rybak, et al.
Infectious Diseases and Therapy
|
April 6, 2020
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
Sara Alosaimy, Noor L Sabagha, Abdalhamid M Lagnf, et al.
The Japanese Journal of Antibiotics
|
October 17, 1998
[The 3rd Japanese-United States Vancomycin Forum]
K Shimada, A Saito, K Yamaguchi, et al.
Antimicrobial Agents and Chemotherapy
|
June 26, 2013
Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection
Anthony M Casapao, Steven N Leonard, Susan L Davis, et al.
Journal of Clinical Microbiology
|
July 11, 2008
Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin
Zukile Gqada, Ben Marais, Elizabeth Wasserman, et al.
The Journal of Antimicrobial Chemotherapy
|
August 10, 2013
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
Ravina Kullar, Anthony M Casapao, Susan L Davis, et al.
Antibiotics (Basel, Switzerland)
|
March 25, 2022
Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR <i>Enterococcus faecium</i>
Katherine Lev, Ashlan J Kunz Coyne, Razieh Kebriaei, et al.
Page
of 54
Search research articles
Search
Showing results (431-440 of 531) with videos related to
Sort By:
Page
of 54
Microbiology Spectrum
|
March 29, 2022
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections <i>In Vitro</i>: Bacteriophage-Antibiotic Combination
Razieh Kebriaei, Katherine L Lev, Rahi M Shah, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an <i>In Vitro</i> Biofilm Model
Seyedehameneh Jahanbakhsh, Nivedita B Singh, Juwon Yim, et al.
Antimicrobial Agents and Chemotherapy
|
November 30, 2016
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Evan J Zasowski, Trang D Trinh, Kimberly C Claeys, et al.
Antimicrobial Agents and Chemotherapy
|
December 30, 2015
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure
Justin R Lenhard, Tanya Brown, Michael J Rybak, et al.
Infectious Diseases and Therapy
|
April 6, 2020
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
Sara Alosaimy, Noor L Sabagha, Abdalhamid M Lagnf, et al.
The Japanese Journal of Antibiotics
|
October 17, 1998
[The 3rd Japanese-United States Vancomycin Forum]
K Shimada, A Saito, K Yamaguchi, et al.
Antimicrobial Agents and Chemotherapy
|
June 26, 2013
Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection
Anthony M Casapao, Steven N Leonard, Susan L Davis, et al.
Journal of Clinical Microbiology
|
July 11, 2008
Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin
Zukile Gqada, Ben Marais, Elizabeth Wasserman, et al.
The Journal of Antimicrobial Chemotherapy
|
August 10, 2013
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
Ravina Kullar, Anthony M Casapao, Susan L Davis, et al.
Antibiotics (Basel, Switzerland)
|
March 25, 2022
Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR <i>Enterococcus faecium</i>
Katherine Lev, Ashlan J Kunz Coyne, Razieh Kebriaei, et al.
Page
of 54